Home Products Most Popular Contact
No items in your cart.

Hematopoietic Stem Cell Transplantation (Online CE Course)

(based on 54 customer ratings)

Author: David M. Falleur, M.Ed., MT(ASCP)
Reviewer: Leah Coppolino, MPH, MLS(ASCP)

Hematopoietic stem cell (HSC) transplantation has become a procedure that offers hope to many patients with cancer and other life-threatening diseases. This course aims to provide information about the importance of HSC transplantation and the role played by the clinical laboratory in HSC collection, processing, administration, and the patient's ongoing care after transplant. The sources of HSCs used in transplants, their application in the treatment of malignant and nonmalignant disorders, and the complications associated with HSC transplantation are also discussed.

See all available courses »

Continuing Education Credits

P.A.C.E.® Contact Hours (acceptable for AMT, ASCP, and state recertification): 1.5 hour(s)
Course number 578-009-17, approved through 2/28/2019
Course number 20-563607, approved through 9/1/2018

Objectives

  • Identify the three sources of hematopoietic stem cells (HSCs).
  • Describe the appropriate use of umbilical cord, bone marrow, and peripheral stem cells in the treatment of malignant and nonmalignant disorders.
  • Describe the role of the clinical laboratory in HSC collection, processing, administration, and patient care following transplantation.
  • Recognize complications associated with HSC transplantation and procedures to prevent or minimize them.
  • Support the National Marrow Donor Registry and their "Be the Match" campaign by providing information to the laboratory community and the general public about the importance of HSC transplantation.

Customer Ratings

(based on 54 customer ratings)

Course Outline

Click on the links below to preview selected pages from this course.
  • Overview and History
      • Overview and History
  • Hematopoietic Stem Cells
      • Hematopoietic Stem Cells (HSCs)
      • Progenitor Cells
      • Important Definitions
      • Which CD antigen is present on hematopoietic stem cells (HSCs)?
  • Sources of Hematopoietic Stem Cells
  • Preservation and Infusion of HSCs
      • Preservation and Infusion of HSCs
      • What agent is used as a cryopreservative for long-term storage of HSCs?
      • Scenario: A transplant patient is tested for T cells after immunosuppression therapy. The following data is obtained by flow cytometry from the patien...
      • Successful engraftment of a hematopoietic stem cell transplant depends on many factors. Which of the following choices are associated with a graft fai...
  • Human Leukocyte Antigen Testing for HSC Transplantation
      • Human Leukocyte Antigens (HLAs) and HSC Transplantation
      • Donor and Recipient Testing of Human Leukocyte Antigens (HLAs)
      • Match the class of the MHC antigens with the appropriate term/description.
      • What type of specimen is used for HLA typing of prospective donors by the National Marrow Donor program?
  • Recruiting and Matching Donors with Patients
      • Finding Donors for Transplant Patients
      • Donor Requirements and Testing
      • Matching Donors with Transplant Recipients
      • What US organization has as its major goal, the recruitment of donors for allogeneic HSC transplants?
      • Which of the following would exclude a potential HSC donor from the National Marrow Registry?
  • Preparing the Patient for Transplant
  • Hematopoietic Diseases Treatable by HSCs
      • Treatment of Hematologic Diseases by HSC Transplantation
      • Which of the following would be the treatment of choice for a pediatric patient with acute lymphoblastic leukemia (ALL) who had acute GVHD from a prio...
      • Which hematologic malignancy is most commonly treated with an allogeneic HSC transplant?
  • Nonhematopoietic Diseases Treated by HSCs
  • Complications of HSC Transplantation
      • Graft versus Host Disease
      • Graft Failure
      • Relapse
      • Infection
      • Late Effects After HSC Transplantation
      • ABO Incompatibility in HSC Transplants
      • Graft Versus Tumor Effect
      • What is the most likely cause of secondary malignancy in HSC transplant patients?
      • What laboratory test result might indicate that a patient is experiencing GVHD?
      • Which of the following factors may precipitate a graft versus host disease (GVHD) reaction to occur?
  • Acknowledgements
  • References
      • References

Additional Information

Level of Instruction: Beginning to intermediate

Intended audience: Medical laboratory scientists, medical technologists, and technicians. This course is also appropriate for clinical laboratory science students and pathology residents.

Author information: David Falleur, M.Ed, MT(ASCP) is an Associate Professor in the Clinical Laboratory Science Program at Texas State University in San Marcos, Texas. David has more than 40 years of teaching experience in hematology and clinical chemistry. David has been active at the national level serving as Annual Meeting Chair for the ASCLS Annual Meeting in 2015 and at the state level as President of the Texas Association for Clinical Laboratory Science.

Reviewer information: Leah Coppolino, MPH, MLS(ASCP) is a Program Director for MediaLab, Inc. Leah was previously the Director of the Medical Laboratory Science Program at St. Christopher’s Hospital for Children in Philadelphia, Pennsylvania. She holds a Masters in Public Health from Thomas Jefferson University.

Course description: Hematopoietic stem cell (HSC) transplantation has become a procedure that offers hope to many patients with cancer and other life-threatening diseases. This course aims to provide information about the importance of HSC transplantation and the role played by the clinical laboratory in HSC collection, processing, administration, and the patient's ongoing care after transplant. The sources of HSCs used in transplants, their application in the treatment of malignant and nonmalignant disorders, and the complications associated with HSC transplantation are also discussed. 

16808 lores
Auer rod in myeloblast
Hematopoiesis cell types scheme_Shutterstock
SH DIC   Graft vs Host.JPG
cytomegalovirus
How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 103 CE courses, most popular
$95 Add to cart
Pick Your Courses
Up to 8 CE hours
$50 Add to cart
Individual course$20 Add to cart


16808 lores


Auer rod in myeloblast


Hematopoiesis cell types scheme_Shutterstock


SH DIC   Graft vs Host.JPG


cytomegalovirus